Twitter Linkedin
Search
Close
Twitter Linkedin
Search
Close
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Working at Boyds
    • Join Us
  • Services
    • Product Development
      • Due Diligence
      • Toxicology Consulting
    • Regulatory Affairs
      • Regulatory and Medical Writing
      • Toxicology Consulting
    • Clinical Operations
      • Study Start-Up
      • Site Monitoring
      • Clinical Project Management
      • Biostatistics
    • Clinical and Medical Affairs
      • Scientific and Medical Advice
      • Medical Monitoring
      • Safety and Pharmacovigilance
  • Regulatory Updates
  • Latest
    • News
    • Blogs
    • Events
  • Resources
  • Contact
Menu
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Working at Boyds
    • Join Us
  • Services
    • Product Development
      • Due Diligence
      • Toxicology Consulting
    • Regulatory Affairs
      • Regulatory and Medical Writing
      • Toxicology Consulting
    • Clinical Operations
      • Study Start-Up
      • Site Monitoring
      • Clinical Project Management
      • Biostatistics
    • Clinical and Medical Affairs
      • Scientific and Medical Advice
      • Medical Monitoring
      • Safety and Pharmacovigilance
  • Regulatory Updates
  • Latest
    • News
    • Blogs
    • Events
  • Resources
  • Contact

Blog

UK continues to lead in Advanced Therapies

Read More

National DNA Day: Gene Therapy – The future has arrived.

Read More

World Cancer Day: The future of cancer treatment and the health equity gap

Read More

Siobhan Gaynor: From Drug Developer to Patient

Read More

Advanced therapies in the UK

Read More

A brave new world for medical technologies

Read More

Supporting the creation of new biotech companies from academia

Read More

Supporting the development of treatments for rare diseases – it’s in our DNA

Read More

Preventing fake medicines from reaching patients

Read More

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.
Sign Up

Speak to a member of the team today

Contact Us

Contact Us

T +44 (0)1270 270010
E info@boydconsultants.com

Twitter Linkedin

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical and Medical Affairs

Tweets

Orphan Drug Designation in the US: Why does it matter?

Read our … latest article, written by Katy Rudnick, investigating how and why small pharmas should get onboard to help develop medicines effective in the treatment of orphan diseases. https://t.co/X6g4HLDfGM

Reply on Twitter 1526851531705749506Retweet on Twitter 15268515317057495061Like on Twitter 15268515317057495062Twitter 1526851531705749506

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical & Medical Affairs

Contact Us

T +44 (0)1270 270010
E info@boydconsultants.com

Twitter Linkedin

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

©2022 Boyds. Boyds is a trading name of Alan Boyd Consultants Ltd. Registered in England & Wales 5395927

Privacy Policy      Contact

arrow